Search

Search Results

• Serious Adverse Events in Hematopoietic Stem Cell Donors: A Literature Review

  Elena Vitalevna Kuzmich, I.E. Pavlova, T.V. Glazanova, L.N. Bubnova

  327-334

  01.07.2026

• High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in the Third- and Subsequent-Line Therapy for Relapsed/Refractory Classical Hodgkin Lymphoma

  Vladislav Olegovich Sarzhevskiy, Yu.V. Protopopova, N.E. Mochkin, E.A. Demina, A.A. Mamedova, A.A. Samoylova, V.S. Bogatyrev, A.A. Rukavisyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko

  310-319

  01.07.2026

• Anorectal Complications of Chemotherapy in Oncohematologic Patients

  Svetlana Vitalevna Shtyrkova, Z.T. Fidarova, A.I. Kashlakova, Yu.A. Chabaeva, S.M. Kulikov, K.I. Danishian, V.V. Troitskaya, E.N. Parovichnikova

  211-219

  01.04.2026

• Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program

  Liudmila Valerevna Fedorova, N.B. Mikhailova, K.V. Lepik, A.M. Chekalov, O.G. Smykova, V.V. Markelov, G.S. Tumyan, A.A. Semenova, A.V. Arakelyan, L.S. Butaev, Iu.A. Oleinik, V.V. Ptushkin, Ya.K. Mangasarova, A.U. Magomedova, E.S. Gitelzon, N.G. Gabeeva, D.A. Koroleva, A.K. Smolianinova, E.E. Zvonkov, Iu.S. Osipov, N.V. Stepanova, T.V. Krinitsina, Yu.I. Podmankova, G.N. Khusainova, L.F. Mukharlyamova, O.R. Smirnova, I.V. Ishmatova, A.A. Zverkova, S.S. Elkhova, S.A. Volchenkov, I.S. Zyuzgin, D.D. Ivanova, E.A. Baryakh, E.N. Misyurina, P.A. Zeinalova, F.M. Abbasbeyli, O.L. Timofeeva, Yu.E. Ryabukhina, M.A. Ulyanova, V.V. Basmanova, T.N. Tsyganok, V.Yu. Kimaikina, S.V. Samarina, E.V. Zubkova, S.V. Ovanesyan, A.I. Iskhakova, A.Yu. Kuvshinov, A.A. Kuzyaeva, G.K. Isaeva, M.I. Andrievskikh, O.Yu. Arzhanukhina, T.V. Shelekhova, I.V. Morozova, P.V. Makarovskaya, O.S. Samoilova, I.V. Vasileva, A.Yu. Terekhova, N.A. Falaleeva, V.A. Shuvaev, S.V. Vlasova, V.A. Lapin, V.I. Bakhtina, A.D. Kulagin

  180-190

  01.04.2026

• Pregnancy Management in Patients with Ph-Negative Myeloproliferative Neoplasms: A Literature Review and Case Report

  Kristina Teimurazovna Poghosyan, A.L. Melikyan, E.A. Gilyazitdinova, I.N. Subortseva, Z.V. Tratsevskaya, E.S. Polushkina, E.E. Sudneva, E.A. Kitsenko

  220-228

  01.04.2026

• Level and Serum Metabolism of Homocysteine in Chronic Myeloid Leukemia Patients: A Literature Review

  K.S. Samarina, Yuliana Yurevna Assesorova, I.V. Berger

  162-171

  01.04.2026

• Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

  Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin

  49-58

  01.01.2026

• Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

  T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, E.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, M.O. Ivanova, T.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, E.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, A.D. Kulagin

  14-26

  01.01.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• Characteristic Features of COVID-19 and Opportunities for Its Prevention in Multiple Myeloma Patients

  Darya Aleksandrovna Chebykina, I.I. Krobinets

  96-103

  01.01.2026

• Pathogenesis of Respiratory Distress in Acute Leukemia with Hyperleukocytosis

  Regina Ramilevna Tukhvatullina, N.V. Matinyan, T.T. Valiev, O.A. Ignatenko, N.V. Kokosadze, S.R. Varfolomeeva

  372-379

  01.10.2025

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Efficacy and Safety of Ruxolitinib in Primary Myelofibrosis Patients with Abdominal Thrombotic Complications: A Case Series

  Yu.P. Martinova, E.V. Borovitskaya, S.S. Lebedeva, E.R. Efimova, O.E. Filippova, K.M. Chernysh, A.P. Smaglyuk, L.I. Napso, N.V. Novospasskaya, L.V. Kucheryavykh, Tamara Vangelevna Chitanava

  250-256

  01.07.2025

• A Rare Case of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

  Anastasiya Gennadevna Kolgotina, L.A. Kramynin, I.V. Ishmatova, L.V. Filatova, P.A. Sapronov, M.V. Grinkevich, A.L. Muravtseva, I.S. Zyuzgin

  277-285

  01.07.2025

• Which Calculations Are Required for Treating Patients with Multiple Myeloma?

  Aleksander Sergeevich Luchinin, A.A. Semenova

  218-226

  01.07.2025

• Sociomedical Profile and Quality of Life of Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Pathogenetic Therapy

  T.I. Ionova, A.D. Kulagin, E.A. Lukina, V.V. Ptushkin, E.G. Arshanskaya, T.N. Babaeva, B.A. Bakirov, S.V. Voloshin, G.P. Dimov, O.U. Klimova, E.Yu. Komarceva, O.L. Panteleeva, R.V. Ponomarev, T.I. Pospelova, S.V. Samarina, N.O. Saraeva, K.O. Farizova, M.N. Finyakina, A.A. Shutylev, D.A. Lipatova, N.M. Porfirieva, Tatyana Pavlovna Nikitina

  197-208

  01.07.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• IV Scientific and Practical Conference "Modern Approaches to Diagnosis and Treatment of Hematological Diseases"; II Scientific Conference "Cellular Technologies in Oncohematology".. Abstracts of papers and reports.

  20.05.2025

• Esophagogastric Bleedings in Patients with Ph-Negative Myeloproliferative Neoplasms and Extrahepatic Portal Hypertension

  Pavel Artemovich Batrov, K.I. Danishian, E.P. Sysoeva, K.R. Sabirov, O.M. Averbukh, O.A. Soboleva, E.A. Kitsenko, E.A. Lukina

  163-170

  01.04.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• Bone Lesions in Adults with Gaucher Disease Type 1: Incidence, Clinical Features, Bone and Joint Complications, as well as Disability Issues

  Vasilii Evgenevich Mamonov, Yu.A. Chabaeva, R.V. Ponomarev, E.A. Lukina

  92-104

  01.01.2025

• Efficacy and Toxicity of Cytarabine + G-CSF, Cyclophosphamide + G-CSF, and Plerixafor + G-CSF Mobilization of Autologous Hematopoietic Stem Cells in Hematologic Malignancy Patients with Predicted Poor Collection

  Svetlana Sergeevna Elkhova, L.V. Filatova, I.S. Zyuzgin, S.A. Volchenkov, L.A. Kramynin, T.Yu. Semiglazova

  86-91

  01.01.2025

• Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

  Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis

  404-414

  01.10.2024

• Primary Immune Thrombocytopenia in Children: An Analysis of the Therapy Efficacy in Compliance with the National Clinical Guidelines

  Maksim Yurevich Rykov, M.Yu. Rykov

  285-290

  01.07.2024

• III scientific-practical conference conference “Modern approaches to the diagnosis and treatment of hematological diseases”

  30.05.2024

• Ibrutinib in Chronic Lymphocytic Leukemia Therapy for High- and Very-High-Risk Patients over 60 Years of Age

  Nadezhda Viktorovna Kurkina, E.A. Repina, E.I. Gorshenina, V.O. Kurkina, P.V. Volkova, A.A. Repin

  37-42

  17.05.2024

• The Role of Polymorphic Variants of Р450 Cytochrome Genes as well as Genes GSTP1 and MDR1 in Toxic Complications of Program Drug Chemotherapy for Classical Hodgkin Lymphoma

  Yana Yurevna Shebunyaeva

  141-153

  01.04.2024

• Risk Factors for Relapses of Perianal Infectious Complications in Patients with Hematological Malignancies: Results of a Single-Center Prospective Trial

  Svetlana Vitalevna Shtyrkova, K.I. Danishyan, E.N. Parovichnikova

  204-212

  01.04.2024

• Cardiovascular Complications of the Immunotherapy of Hematological Malignancies: A Literature Review

  Geliya Rifkatovna Gimatdinova, O.E. Danilova, V.P. Kuzmin, G.I. Davydkin, Yu.V. Kostalanova, D.A. Kudlai, I.L. Davydkin

  407-412

  28.09.2023

• Supportive Therapy in Multiple Myeloma: Practical Recommendations

  Maksim Valerevich Solovev, M.V. Soloveva, L.P. Mendeleeva

  426-448

  28.09.2023

• New Approaches to Cardiovascular Toxicity Assessment in Patients with Hematological Malignancies: A Literature Review

  O.E. Danilova, Geliya Rifkatovna Gimatdinova, I.L. Davydkin, O.V. Tereshina, V.D. Sabanova, G.I. Davydkin

  331-336

  09.06.2023

• Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

  Elena Romanovna Shilova, N.A. Romanenko, D.A. Chebykina, T.V. Glazanova, M.N. Zenina, I.E. Pavlova, S.S. Bessmeltsev

  321-330

  09.06.2023

• The Role of Leukocytes in the Formation of Neutrophil Extracellular Traps and Thrombosis in Ph-Negative Myeloproliferative Neoplasms: A Literature Review

  Boldukyz Tolgonbaevna Dzhumabaeva

  263-267

  09.06.2023

• Dynamics of SARS-CoV-2 RNA Detection in Patients and Employees of the National Research Center for Hematology During the First Two Years of the Novel COVID-19 Pandemic

  Oksana Gazimagomedovna Starkova, D.S. Tikhomirov, A.Yu. Krylova, I.O. Snezhko, E.N. Ovchinnikova, O.A. Aleshina, T.A. Tupoleva, T.V. Gaponova

  186-191

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Prognostic Models in Medicine

  Aleksander Sergeevich Luchinin

  27-36

  01.01.2023

• Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports

  D.V. Motorin, L.L. Girshova, E.G. Lomaia, Yu.A. Alekseeva, A.V. Petukhov, V.V. Ivanov, E.K. Antonov, S.V. Efremova, A.I. Reshetova, E.N. Tochenaya, Aleksina Alekseevna Shatilova, E.N. Tochenaya, A.V. Petrov, T.S. Nikulina, K.V. Bogdanov, D.V. Ryzhkova, Yu.V. Mirolyubova, I.E. Prokop’ev, I.G. Budaeva

  69-79

  01.01.2023

• Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

  L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian, G.M. Galstyan

  349-355

  01.10.2022

• Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step

  M.A. Granatkin, Evgenii Aleksandrovich Nikitin, E.S. Mikhailov, V.A. Doronin, S.V. Minenko, M.M. Okuneva, N.V. Degtyareva, M.E. Pochtar, S.A. Lugovskaya, Yu.N. Kobzev, O.Yu. Vinogradova, V.V. Ptushkin

  282-288

  01.07.2022

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022